IP Library Granted Patent US 7,534,819
Granted Patent B2
US 7,534,819 · App. 11/150,588 · Granted May 19, 2009

Compositions and methods for intracellular delivery of biotinylated cargo

Assignee: University of Washington
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,819
App. No.
11/150,588
Granted
May 19, 2009
Kind
B2
Abstract

The invention provides compositions for intracellular delivery of biotinylated cargo. The compositions comprise a complex formed between (a) a fusion protein comprising a protein transduction domain linked to streptavidin and (b) a biotinylated cargo for intracellular delivery. In some embodiments, the protein transduction domain comprises the protein transduction domain of the Human Immunodeficiency Virus type 1 (HIV-1) TAT protein. The complex may further comprise a biotinylated endosomal releasing polymer, such as a poly(propylacrylic acid) polymer. The invention also provides methods for obtaining intracellular delivery of biotinylated cargo and methods for obtaining cytoplasmic delivery of biotinylated cargo.

Claims (10)

1. A composition, comprising a complex formed between (a) a fusion protein comprising a protein transduction domain linked to streptavidin (b) a biotinylated cargo for intracellular delivery and (c) a (propylacrylic acid)-containing polymer.

2. The composition of claim 1 , wherein the protein transduction domain comprises the protein transduction domain of the Human Immunodeficiency Virus type 1 (HIV-1) TAT protein.

3. The method of claim 1 , wherein the (propylacrylic acid)-containing polymer is poly(propylacrylic acid).

4. The composition of claim 1 , wherein the (propylacrylic acid)-containing polymer is biotinylated.

5. A method for obtaining intracellular delivery of biotinylated cargo, comprising the step of exposing cells to a complex comprising (a) a fusion protein comprising a protein transduction domain linked to streptavidin to obtain intracellular delivery of the biotinylated cargo (b) a biotinylated cargo and (c) a (propylacrylic acid)-containing polymer.

6. The method of claim 5 , wherein the protein transduction domain comprises the protein transduction domain of the HIV-1 TAT protein.

7. The method of claim 5 , wherein the (propylacrylic acid)-containing polymer is biotinylated.

8. A method for obtaining cytoplasmic delivery of biotinylated cargo, comprising the step of exposing cells to a complex comprising (a) a fusion protein comprising a protein transduction domain linked to streptavidin to obtain cytoplasmic delivery of the biotinylated cargo, (b) a biotinylated cargo, and (c) a biotinylated (propylacrylic acid)-containing polymer.

9. The method of claim 8 , wherein the (propylacrylic acid)-containing polymer is poly(propylacrylic acid).

10. The method of claim 9 , wherein the protein transduction domain comprises the protein transduction domain of the HIV-1 TAT protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 16, 2008
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021533/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2006
From: ALBARRAN, BRIAN; STAYTON, PATRICK S.; TO, RICHARD
To: UNIVERSITY OF WASHINGTON
Reel/Frame 017038/0877 →
Continuity (1)
Related Publication 20060281677A1 · Dec 14, 2006